LiquidHALLMARK®
Resources
Publications
News & Events
Patients
Company
About Us
News & Events
Careers
Contact Us
Portal Login
News & Events
Show Filters
News
View
All
News
No Record Found
News
Lucence secures US Medicare approval for its cancer tests
20 March 2023
News
Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer
22 February 2023
News
Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022
23 October 2022
News
Lucence and Omnigen Partner to bring Amplicon-based Liquid Biopsy Tests to Turkey
18 October 2022
News
Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer
26 September 2022
News
Local Study Demonstrates Synergies of Using Blood-based Liquid Biopsies to complement Tissue Biopsies for Lung Cancer Diagnosis
28 July 2022
News
Lucence Presents Data at 2022 World Conference on Lung Cancer (WCLC) Supporting Utility of Amplicon-Based Liquid Biopsy
14 July 2022
News
Lucence Showcases Promising Data on ctDNA and ctRNA Liquid Biopsy Assay for Lung Cancer at 2022 ASCO Annual Meeting
31 May 2022
1
2
3
Lucence secures approval for its Singapore-invented cancer tests from Medicare
>